ABT-869

CAT: 0026-1615-5Size: 5 mgDry Ice: NoHazardous: No
CAT#:0026-1615-5Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ABT-869 is multi-targeted inhibitor of all members of the VEGF and PDGF receptor families (e.g., KDR, IC₅₀ value of 4 nM), but has much less activity (IC₅₀ values >1 µM) against unrelated receptor tyrosine kinases, soluble tyrosine kinases or serine/threonine kinases. The kinase inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC₅₀ values of 2, 4 and 7 nM for PDGFRβ, KDR and CSF-1R, respectively) and VEGF-stimulated proliferation (0.2 nM IC₅₀ for human endothelial cells).
Shipping Conditions
RT
Storage Conditions
-20°C
Shelf Life
24months

Related Products

CatalogName
2463-5ABT-737
2467-25ABT-263
2463-25ABT-737
2467-5ABT-263
1620-5ABT-888
1620-1ABT-888
B1947-25ABT-494
B1947-5ABT-494
B2486-5EZSolution™ABT-494 (Upadacitinib)
2253-5BCl-2 Inhibitor, ABT-199

Alternative Products

CatalogName
abx182361-01ABT-869
MBS8506184-01Linifanib (ABT-869)
A10025-200Linifanib (ABT-869) 200mg
A10025-5Linifanib (ABT-869) 5mg
A10025-100Linifanib (ABT-869) 100mg
A10025-10Linifanib (ABT-869) 10mg
A10025-25Linifanib (ABT-869) 25mg
A10025-50Linifanib (ABT-869) 50mg
A10025-500Linifanib (ABT-869) 500mg
TBI5268-25MGABT-869, VEGFR/PDGFR family inhibitor

Popular Products